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Introduction
Predicting disease course in Juvenile Idiopathic Arthritis
(JIA) is difficult. During the first 6 months of oligoarticu-
lar JIA (O-JIA) disease presents with 4 or fewer affected
joints, however after 6 or more months severity might
increase with more than 4 joints involved (extended
O-JIA), or persist with 4 or fewer joints affected (persis-
tent O-JIA). However patients do not show any clinical
differences at onset making a decision on treatment strat-
egy difficult before extension occurs. It has previously
been shown that the CD4/CD8 T cell ratio in extended-
to-be patients (samples before extension has occurred) is
lower compared to those who persist (Hunter et al 2010),
and thus might be a useful biomarker in predicting the
course of disease. However measuring this cell ratio cur-
rently requires specialized expertise. To translate the
measurement of the CD4/8 synovial T cell ratio as a bio-
marker a method is needed, which could be used in a
wide range of hospital facilities, hence a real-time quanti-
tative PCR (qPCR) method was tested.
Objectives
The aim of this study was to measure CD4 and CD8
mRNA in whole synovial fluid collected at therapeutic
joint injection and to compare it to the gold standard of
flow cytometry using mononuclear cells.
Methods
A total of 40 healthy adult blood and 20 patient synovial
fluid (SF) samples were included in this study. cDNA
was generated from total RNA extracted from Tempus
vacutainers using whole blood or SF. CD4, CD8b and
GAPDH transcripts were measured by qPCR. Simulta-
neously peripheral blood mononuclear cells (PBMC)
and SFMC were isolated using density gradient centrifu-
gation and stained with CD3, CD4, CD8b and CD8a for
flow cytometry.
Results
Validating previous results, the CD4/CD8 T-cell ratio
measured by flow cytometry was significantly lower in
SFMC than in healthy adult PBMC. Measurement of
CD4/8 ratio by qPCR and flow cytometry showed some
correlation in healthy adult PBMC. However CD4/CD8
ratios by qPCR were higher in SF samples compared to
healthy control PBMC. This was driven by increased
CD4 measurements by qPCR in SF samples.
Conclusion
Taken together these data show a trend to a correlation
of qPCR and flow cytometry methods in healthy adult
control samples. The increased level of CD4 transcript
in SF measured by qPCR might well be due to the abun-
dance of neutrophils and monocytes, which are/may be
discarded during preparation of SFMC for flow cytome-
try. Whether qPCR measurement of CD4/CD8 ratio can
be used as a predictive biomarker for severity of disease
course in O-JIA remains to be seen, and will be assessed
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